Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marie-Laure Couec"'
Autor:
Marie Gérardin, Morgane Rousselet, Marie-Laure Couec, Agathe Masseau, PHEDRE Group, Aurélie Aquizerate, Nicolas Authier, Sylvie Deheul, Anne Roussin, Joelle Micallef, Samira Djezzar, French Addictovigilance Network (FAN), Fanny Feuillet, Pascale Jolliet, Marie Grall-Bronnec, Caroline Victorri-Vigneau
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background In many countries, nitrous oxide is used in a gas mixture (EMONO) for short-term analgesia. Cases of addiction, with significant misuse, have been reported in hospitalized patients. Patients suffering from sickle cell disease (SCD
Externí odkaz:
https://doaj.org/article/77e98a81ec994b808b6cd844d784b309
Autor:
Marie Emilie Dourthe, Anne Auperin, Charlotte Rigaud, Melissa Barbati, Jacinthe Bonneau, Nimrod Buchbinder, Marie-Laure Couec, Peggy Dartigues, Stéphane Ducassou, Nathalie Garnier, Stéphanie Haouy, Bénédicte Jonca, Anne Jourdain, Amaury Leruste, Thierry Molina, Françoise Montravers, Marlène Pasquet, Aurélie Phulpin, Maryline Poirée, Mathieu Simonin, Alexandra Spiegel, Arnauld Verschuur, Thierry Leblanc, Judith Landman-Parker, Catherine Patte, Véronique Minard-Colin
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/eac573cfb94241f5858f6e2f48839d9c
Autor:
Margaux Camuset, Baptiste Le Calvez, Olivier Theisen, Catherine Godon, Audrey Grain, Caroline Thomas, Marie‐Laure Couec, Marie C. Béné, Fanny Rialland, Marion Eveillard
Publikováno v:
Cancer Innovation, Vol 2, Iss 6, Pp 513-523 (2023)
Abstract Background Thanks to an improved therapeutic regimen in childhood B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL), 5 year‐overall survival now exceeds 90%. Unfortunately, the 25% of children who relapse have an initial poor pro
Externí odkaz:
https://doaj.org/article/b396003c039c459b98a935e100730366
Autor:
Marie Emilie Dourthe, Aurélie Phulpin, Anne Auperin, Jacques Bosq, Marie-Laure Couec, Peggy Dartigues, Stéphane Ducassou, Nathalie Garnier, Stéphanie Haouy, Thierry Leblanc, Amaury Leruste, Catherine Paillard, Charlotte Rigaud, Mathieu Simonin, Catherine Patte, Véronique Minard-Colin
Publikováno v:
Haematologica, Vol 107, Iss 9 (2022)
Primary mediastinal large B-cell lymphoma (PMLBL) is a rare entity predominantly affecting adolescents and young adults. Recently, an international phase II trial in pediatric patients using dose-adjusted etoposide, doxorubicin, and cyclophosphamide
Externí odkaz:
https://doaj.org/article/dc36da9496274a998e1824bef6ed74f6
Autor:
Marie Gerardin, Morgane Rousselet, Marie-Laure Couec, Agathe Masseau, Marylène Guerlais, Nicolas Authier, Sylvie Deheul, Anne Roussin, Joelle Micallef, Samira Djezzar, French Addictovigilance Network (FAN), Fanny Feuillet, Pascale Jolliet, Caroline Victorri-Vigneau
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248649 (2021)
BackgroundSickle cell disease (SCD) induces chronic haemolytic anaemia and intermittent vaso-occlusion that results in tissue ischaemia causing acute, severe pain episodes that can lead to frequent hospitalizations. These consequences can have reperc
Externí odkaz:
https://doaj.org/article/69365087b7b44f49a736eda8e92119c0
Autor:
Marie Emilie Dourthe, Aurélie Phulpin, Anne Auperin, Jacques Bosq, Marie-Laure Couec, Peggy Dartigues, Stéphane Ducassou, Nathalie Garnier, Stéphanie Haouy, Thierry Leblanc, Amaury Leruste, Catherine Paillard, Charlotte Rigaud, Mathieu Simonin, Catherine Patte, Véronique Minard-Colin
Publikováno v:
Haematologica. 107(9)
Primary mediastinal large B-cell lymphoma (PMLBL) is a rare entity predominantly affecting adolescents and young adults. Recently, an international phase II trial in pediatric patients using dose-adjusted etoposide, doxorubicin, and cyclophosphamide
Autor:
Nathalie Aladjidi, Anne Lambilliotte, Thierry Leblanc, Mylène Duplan, Nathalie Garnier, Marie-Laure Couec, David Grand, Veronique Minard-Colin, Laurence Lamant, Geneviève Plat, Nimrod Buchbinder, Claudine Schmitt, Rachid Abbas, Charlotte Rigaud, Laurence Brugières
Publikováno v:
Pediatric bloodcancerREFERENCES. 68(6)
In anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALK+ ALCL), positive minimal residual disease (MRD+) after the first chemotherapy course was proven of strong prognostic significance. We aimed to validate these results in
Autor:
Eric Jeziorski, Yves Bertrand, Flore Sicre de Fontbrune, Virginie Gandemer, Blandine Beaupain, Frédéric Millot, Jean Donadieu, François Delhommeau, Jean-Alain Martignoles, Marie-Laure Couec, Claude Preudhomme, Laetitia Largeaud, Cecile Renard, Nathalie Aladjidi, Pierre-Simon Rohrlich, Wadih Abou Chahla, Claire Fieschi, Sophie Kaltenbach, Stéphane Blanche, Despina Moushous, Pierre Hirsch, Isabelle Meyts, Guy Leverger, Thomas Longval, Jean Louis Stephan, Vincent Barlogis, Aline Moignet Autrel, Fanny Fouyssac, Dalila Adjaoud, Marlène Pasquet, Olivier Tournilhac, Vahid Asnafi, Patrick Revy, Pascale Flandrin-Gresta, Christine Bellanné-Chantelot, Liana Carausu, Nawa Hachem, Thierry Leblanc, Hélène Lapillonne, Jean Soulier, Mira El-Khoury
Publikováno v:
Blood. 136:22-23
Introduction : Hematological complications (HC) as Aplastic anemia (AA) and myelodysplasia and acute leukemia (MDS/AL) are frequent and life threatening in patients with Shwachman Diamond Syndrome (SDS) with SBDS mutations. The therapy of such events
Autor:
Virginie Gandemer, Jean Michon, Anne Jourdain, Catherine Patte, Geneviève Plat, Nathalie Aladjidi, Charlotte Rigaud, Thierry Leblanc, Veronique Minard-Colin, Anne Lambliotte, Judith Landman-Parker, Marie-Laure Couec, Anne Auperin, Stéphanie Haouy
Publikováno v:
Pediatric bloodcancer. 66(9)
Introduction In order to describe relapsed B-cell non-Hodgkin lymphoma and mature acute leukemia in children/adolescents treated with the Lymphomes Malins B (LMB) regimen and their outcome in the rituximab era, relapses in the French LMB2001 study we
Autor:
Nicolas André, Odile Minckes, Marie-Laure Couec, Franck Bourdeaut, Perrine Marec Bérard, Estelle Thebaud, Pierre Leblond, Nadège Corradini, Isabelle Aerts, Xavier Rialland
Publikováno v:
Pediatric Blood & Cancer. 59:34-38
Background Bevacizumab, a monoclonal antibody targeting the vascular endothelial growth factor, has proven efficacy in some adult tumors; it is now proposed as a new therapeutic strategy for refractory or recurrent brain tumors in some children, eith